Banquisio, Rhianna S.

HRN: 22-75-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CLOXACILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
03/22/2023
03/29/2023
ORAL
5 Ml
Q6h
Burns
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: